Philip B. Komarnitsky

发表论文 82 篇 · 总被引 2581 次 · h-index 20

代表论文

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study (2021 · Journal of Thoracic Oncology · 被引 279)
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study (2021 · Journal of Thoracic Oncology · 被引 163)
Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non–Small Cell Lung Carcinoma (2021 · Clinical Cancer Research · 被引 80)
A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors (2018 · Clinical Cancer Research · 被引 45)
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC (2021 · Journal of Thoracic Oncology · 被引 42)
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours (2018 · British Journal of Cancer · 被引 32)